Balkhy Husam H, Chapman Peter D, Arnsdorf Susan E
Department of Cardiac Surgery, St. Joseph Regional Medical Center, Milwaukee, Wisconsin 53210, USA.
Heart Surg Forum. 2004;7(6):353-5. doi: 10.1532/HSF98.2004-1093.
Surgical therapy for atrial fibrillation (AF) is becoming increasingly popular in the concomitant setting. Minimally invasive techniques are being developed for management of the patient with stand-alone AF. We report on our first case of a patient undergoing thoracoscopic microwave epicardial AF ablation combined with the incorporation of a new device for left atrial appendage (LAA) exclusion.
The patient is a 62-year-old man with a 10-year history of drug-resistant paroxysmal AF. He had failed multiple electrical cardioversions, as well as a percutaneous attempt at left and right superior pulmonary vein (PV) isolation. On October 8, 2003, he was admitted to undergo an off-pump thoracoscopic epicardial microwave ablation. While the patient was under general anesthesia, 3 thoracoscopic access ports were created in the right chest. The pericardium was widely opened. Red rubber catheters were positioned in the transverse and oblique sinuses. The 2 catheters were retrieved on the left side and tied together, forming a guide to the Flex 10 microwave ablation probe (Guidant Corporation, Fremont, CA, USA). The Flex 10 sheath was positioned to encircle all 4 pulmonary veins. The position of the ablation catheter was confirmed visually to be behind the LAA. Sequential ablation was then performed in the segments of the Flex 10 to create a continuous ablation line around the PVs. A connecting lesion to the base of the LAA was then performed. The LAA was then stapled using the SurgASSIST computer-mediated thoracoscopic stapling system (Power Medical Intervention, New Hope, PA, USA).
The procedure was uneventful and lasted for a total of 2.5 hours. The patient was discharged home on postoperative day 2 in rate-controlled AF. He was successfully electrically cardioverted to normal sinus rhythm (NSR). At latest follow-up he remained in NSR and continued to take dofetilide (Tikosyn).
Thoracoscopic epicardial microwave ablation of AF is a technically feasible procedure with minimal risk. The computer deployment and motion controlled stapling system that we used in this case has the potential to become a safe and reliable alternative to conventional stapling instruments.
心房颤动(AF)的外科治疗在合并其他疾病的情况下越来越普遍。目前正在开发用于单独治疗房颤患者的微创技术。我们报告首例接受胸腔镜下心外膜微波消融联合使用一种用于左心耳(LAA)封堵的新装置的患者。
该患者为一名62岁男性,有10年耐药性阵发性房颤病史。他多次电复律失败,经皮尝试左右肺静脉隔离也失败。2003年10月8日,他入院接受非体外循环胸腔镜下心外膜微波消融术。患者全身麻醉后,在右胸做3个胸腔镜入口。广泛打开心包。将红色橡胶导管置于横窦和斜窦。将这2根导管从左侧取出并绑在一起,形成Flex 10微波消融探头(美国加利福尼亚州弗里蒙特市Guidant公司)的引导。将Flex 10鞘管定位以环绕所有4条肺静脉。经视觉确认消融导管位于左心耳后方。然后在Flex 10的各节段进行序贯消融,在肺静脉周围形成连续的消融线。接着进行至左心耳基部的连接性损伤。然后使用SurgASSIST计算机介导胸腔镜缝合系统(美国宾夕法尼亚州新希望市Power Medical Intervention公司)对左心耳进行缝合。
手术顺利,总共持续2.5小时。患者术后第2天以心率控制的房颤出院。他成功电复律为正常窦性心律(NSR)。在最近一次随访时,他仍维持NSR,并继续服用多非利特(Tikosyn)。
胸腔镜下心外膜微波消融房颤是一种技术上可行且风险极小的手术。我们在本病例中使用的计算机部署和运动控制缝合系统有可能成为传统缝合器械安全可靠的替代品。